Heron Therapeutics Inc. Common Stock (HRTX)
Stock · NASDAQ · Health Care
$0.33as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Resistance level
$0.409125
Industry
Biotechnology: Pharmaceutical Preparations
Fundamentals
- Market cap
- $96.80M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How Heron Therapeutics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub
Heron Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- HRTXHeron Therapeutics Inc. Common Stock$0.33▲ 0.00%Market cap $96.80MP/E —
- ONCYOncolytics Biotech Inc. Common Stock$0.8457▼ 0.51%Market cap $92.50MP/E —$1.39$1.44
- ALDXAldeyra Therapeutics Inc. Common Stock$1.49▼ 3.57%Market cap $92.29MP/E —$1.07$6.18
- FBIOFortress Biotech Inc. Common Stock$2.77▼ 1.07%Market cap $91.68MP/E 0.75$2.18$4.53
- VRCAVerrica Pharmaceuticals Inc. Common Stock$5.54▲ 9.27%Market cap $90.19MP/E —$3.28$9.82
- NTHINeOnc Technologies Holdings Inc. Common Stock$4.69▲ 1.74%Market cap $89.73MP/E —$3.01$12.99
- COYACoya Therapeutics Inc. Common Stock$4.59▼ 5.56%Market cap $103.92MP/E —$3.71$7.75
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HRTX Heron Therapeutics Inc. Common Stock | $96.80M | — | $0.33 | ▲ 0.00% | |
| ONCY Oncolytics Biotech Inc. Common Stock | $92.50M | — | $0.8457 | ▼ 0.51% | $1.39$1.44 |
| ALDX Aldeyra Therapeutics Inc. Common Stock | $92.29M | — | $1.49 | ▼ 3.57% | $1.07$6.18 |
| FBIO Fortress Biotech Inc. Common Stock | $91.68M | 0.75 | $2.77 | ▼ 1.07% | $2.18$4.53 |
| VRCA Verrica Pharmaceuticals Inc. Common Stock | $90.19M | — | $5.54 | ▲ 9.27% | $3.28$9.82 |
| NTHI NeOnc Technologies Holdings Inc. Common Stock | $89.73M | — | $4.69 | ▲ 1.74% | $3.01$12.99 |
| COYA Coya Therapeutics Inc. Common Stock | $103.92M | — | $4.59 | ▼ 5.56% | $3.71$7.75 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- HC Wainwright & Co. Downgrades Heron Therapeutics to NeutralBenzinga · 8/11/2026
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga · 8/10/2026
- Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/10/2026
- Heron Therapeutics Q2 EPS $(0.03) Misses $(0.01) Estimate, Sales $37.666M Miss $42.200M EstimateBenzinga · 8/10/2026
Insider Activity
Insider Actions →Acquired
180.4K
Disposed
23.8K
- Hensley Mark Earl · August 6, 2026 · Option Exercise31.3K
- Hensley Mark Earl · August 6, 2026 · Tax Withholding8.9K @ $0.5
- Hensley Mark Earl · July 31, 2026 · Option Exercise11.8K
- Duarte Ira · July 31, 2026 · Option Exercise11.7K
- Duarte Ira · July 31, 2026 · Tax Withholding3.3K @ $0.5
- Collard Craig A · July 31, 2026 · Option Exercise34.8K
- Forbes William P · July 31, 2026 · Option Exercise11.7K
- Forbes William P · July 31, 2026 · Tax Withholding3.3K @ $0.5
- Duarte Ira · July 30, 2026 · Option Exercise13.5K
- Duarte Ira · July 30, 2026 · Tax Withholding3.9K @ $0.5
- Collard Craig A · July 30, 2026 · Option Exercise50.0K
- Forbes William P · July 30, 2026 · Option Exercise11.8K
- Forbes William P · July 30, 2026 · Tax Withholding3.3K @ $0.5
- Duarte Ira · July 19, 2026 · Option Exercise3.9K
- Duarte Ira · July 19, 2026 · Tax Withholding1.1K @ $0.47
Institutional Ownership
March 31, 2026
- Total shares held
- 157.51M
- Total value held
- $125.50M
- Institutional holders
- 164
Top holders this quarter
- Unknown30.05M
- Unknown12.24M
- Unknown10.11M
- Unknown9.82M
- Unknown8.75M
- Unknown7.81M
- Unknown7.63M
- Unknown6.34M
- Unknown6.25M
- Unknown6.14M
See the full, filterable feed with live charts on the MarketWall dashboard.